Characterization of human tibrovirus envelope glycoproteins

Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are lar...

Full description

Saved in:
Bibliographic Details
Published inJournal of Virology Vol. 98; no. 7; p. e0049924
Main Authors Munyeku-Bazitama, Yannick, Saito, Takeshi, Hattori, Takanari, Miyamoto, Hiroko, Lombe, Boniface Pongombo, Mori-Kajihara, Akina, Kajihara, Masahiro, Muyembe-Tamfum, Jean-Jacques, Igarashi, Manabu, Park, Eun-sil, Morikawa, Shigeru, Makiala-Mandanda, Sheila, Takada, Ayato
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 23.07.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.
AbstractList Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.
Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%–48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses.
Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%–48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses.IMPORTANCEHuman tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.
Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%-48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses.Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%-48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses.Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.IMPORTANCEHuman tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.
Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma virus 1 (EKV-1), Ekpoma virus 2, and Mundri virus. However, since none of them has been isolated, their biological properties are largely unknown. We aimed to characterize the human tibrovirus glycoprotein (G), which likely plays a pivotal role in viral tropism and pathogenicity. Human tibrovirus Gs were found to share some primary structures and display 14 conserved cysteine residues, although their overall amino acid homology was low (29%-48%). Multiple potential glycosylation sites were found on the G molecules, and endoglycosidase H- and peptide-N-glycosidase F-sensitive glycosylation was confirmed. AlphaFold-predicted three-dimensional (3D) structures of human tibrovirus Gs were overall similar. Membrane fusion mediated by these tibrovirus Gs was induced by acidic pH. The low pH-induced conformational change that triggers fusion was reversible. Virus-like particles (VLPs) were produced by transient expression of Gs in cultured cells and used to produce mouse antisera. Using vesicular stomatitis Indiana virus pseudotyped with Gs, we found that the antisera to the respective tibrovirus VLPs showed limited cross-neutralizing activity. It was also found that human C-type lectins and T-cell immunoglobulin mucin 1 acted as attachment factors for G-mediated entry into cells. Interestingly, BASV-G showed the highest ability to utilize these molecules. The viruses infected a wide range of cell lines with preferential tropism for human-derived cells whereas the preference of EKV-1 was unique compared with the other human tibroviruses. These findings provide fundamental information to understand the biological properties of the human tibroviruses. Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as high as 60% in humans. However, the extent and burden of human infection as well as factors behind differences in infection outcomes are largely unknown. In this study, we characterized human tibrovirus glycoproteins, which play a key role in virus-host interactions, mainly focusing on their structural and antigenic differences and cellular tropism. Our results provide critical information for understanding the biological properties of these novel viruses and for developing appropriate preparedness interventions such as diagnostic tools, vaccines, and effective therapies.
Author Eun-sil Park
Boniface Pongombo Lombe
Masahiro Kajihara
Hiroko Miyamoto
Manabu Igarashi
Yannick Munyeku-Bazitama
Akina Mori-Kajihara
Jean-Jacques Muyembe-Tamfum
Ayato Takada
Sheila Makiala-Mandanda
Takanari Hattori
Takeshi Saito
Shigeru Morikawa
Author_xml – sequence: 1
  givenname: Yannick
  orcidid: 0000-0001-8303-318X
  surname: Munyeku-Bazitama
  fullname: Munyeku-Bazitama, Yannick
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo, Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
– sequence: 2
  givenname: Takeshi
  surname: Saito
  fullname: Saito, Takeshi
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan
– sequence: 3
  givenname: Takanari
  surname: Hattori
  fullname: Hattori, Takanari
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan
– sequence: 4
  givenname: Hiroko
  surname: Miyamoto
  fullname: Miyamoto, Hiroko
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan
– sequence: 5
  givenname: Boniface Pongombo
  surname: Lombe
  fullname: Lombe, Boniface Pongombo
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, Faculté de Médecine Vétérinaire, Université Pédagogique National, Kinshasa, Democratic Republic of Congo, Central Veterinary Laboratory of Kinshasa, Kinshasa, Democratic Republic of Congo
– sequence: 6
  givenname: Akina
  surname: Mori-Kajihara
  fullname: Mori-Kajihara, Akina
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan
– sequence: 7
  givenname: Masahiro
  surname: Kajihara
  fullname: Kajihara, Masahiro
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan
– sequence: 8
  givenname: Jean-Jacques
  surname: Muyembe-Tamfum
  fullname: Muyembe-Tamfum, Jean-Jacques
  organization: Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo, Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
– sequence: 9
  givenname: Manabu
  surname: Igarashi
  fullname: Igarashi, Manabu
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan
– sequence: 10
  givenname: Eun-sil
  surname: Park
  fullname: Park, Eun-sil
  organization: Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan
– sequence: 11
  givenname: Shigeru
  surname: Morikawa
  fullname: Morikawa, Shigeru
  organization: Department of Microbiology, Faculty of Veterinary Medicine, Okayama University of Science, Ehime, Japan
– sequence: 12
  givenname: Sheila
  surname: Makiala-Mandanda
  fullname: Makiala-Mandanda, Sheila
  organization: Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of Congo, Département de Biologie Médicale, Faculté de Médecine, Université de Kinshasa, Kinshasa, Democratic Republic of Congo
– sequence: 13
  givenname: Ayato
  orcidid: 0000-0003-2464-6642
  surname: Takada
  fullname: Takada, Ayato
  organization: Division of Global Epidemiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan, One Health Research Center, Hokkaido University, Sapporo, Japan, Department of Disease Control, School of Veterinary Medicine, University of Zambia, Lusaka, Zambia
BackLink https://cir.nii.ac.jp/crid/1871429166522079488$$DView record in CiNii
https://www.ncbi.nlm.nih.gov/pubmed/38953631$$D View this record in MEDLINE/PubMed
BookMark eNp1kM1LXDEUxUOx1HHqzrW8hQsLfTbfyaWLIoNtBcFNC92FvEzGibyXjMl7A_avb3Ss6EK43Lu4Pw7nnAO0F1P0CB0RfEYI1V9ut-EMYw7QUv4OzQgG3QpB-B6aYUxpK5j-s48OSwkdJkooAMw_oH2mQTDJyAx9Xaxttm70Ofy1Y0ixSatmPQ02NmPoctqGPJXGx63v08Y3N_29S5ucRh9i-Yjer2xf_OHTnaPf3y9-LX62V9c_LhfnV63liowtJ5yBBOWUZFrDCrhQnYKO4CVWAljXSY2508AsdEvnnCT1Mka91RRLz-bo2053M3WDXzofx2x7s8lhsPneJBvM608Ma3OTtqZWJAWvQefo9Ekhp7vJl9EMoTjf9zb6NBXDqhFWh0BFP-1QWwZqbtOUY81mCH5Q06YWbh4LN5RX9vilsWdH_-utwOcd4HIqJfvVM_KG3skOjyEYFx420YpwCkRKQSlWwLVm_wAM7ZaZ
Cites_doi 10.1128/jvi.78.6.2943-2947.2004
10.1016/j.celrep.2020.108042
10.1016/j.bpj.2016.04.035
10.1006/viro.2002.1730
10.1021/acsomega.2c03517
10.1371/journal.ppat.1002924
10.1371/journal.pntd.0003631
10.1128/JVI.01183-13
10.1128/JVI.78.21.12090-12095.2004
10.3389/fmicb.2019.00856
10.4049/jimmunol.178.9.5839
10.1016/j.chom.2019.12.012
10.1074/jbc.M202104200
10.1038/s41586-021-03819-2
10.1128/mbio.03060-21
10.1016/0378-1135(80)90029-2
10.1371/journal.ppat.1008383
10.1093/infdis/jir334
10.1128/genomeA.00089-15
10.1128/CVI.00170-10
10.1093/glycob/cwy053
10.1038/s41592-022-01488-1
10.1128/JVI.02021-09
10.1371/journal.ppat.1003232
10.1371/journal.ppat.1009910
10.1038/s41467-018-03432-4
10.1071/bi9860225
10.1126/science.aap9072
10.3390/biology12060878
10.1128/jvi.76.10.4855-4865.2002
10.1038/nrmicro3469
10.3390/v14102124
10.1080/14712598.2020.1787981
10.1128/JVI.02265-13
10.1073/pnas.94.26.14764
10.1016/0378-1135(89)90079-5
10.1128/jvi.77.2.1069-1074.2003
10.1084/jem.20021840
10.1126/science.1135710
10.1101/2021.10.04.463034
10.1074/jbc.M708955200
10.3390/v14020210
10.1007/s00018-008-7534-3
10.3390/v12030252
10.1016/bs.aivir.2019.05.003
10.1016/j.vaccine.2014.02.031
10.1099/0022-1317-80-5-1211
10.1016/j.virol.2014.09.009
10.1016/j.virol.2015.11.002
ContentType Journal Article
Copyright Copyright © 2024 American Society for Microbiology.
Copyright © 2024 American Society for Microbiology. 2024 American Society for Microbiology.
Copyright_xml – notice: Copyright © 2024 American Society for Microbiology.
– notice: Copyright © 2024 American Society for Microbiology. 2024 American Society for Microbiology.
DBID RYH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1128/jvi.00499-24
DatabaseName CiNii Complete
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef


MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1098-5514
Editor Heise, Mark T.
Editor_xml – sequence: 1
  givenname: Mark T.
  surname: Heise
  fullname: Heise, Mark T.
ExternalDocumentID PMC11265436
00499-24
38953631
10_1128_jvi_00499_24
Genre Journal Article
GrantInformation_xml – fundername: Japan Agency for Medical Research and Development (AMED)
  grantid: JP23fk0108624
– fundername: Japan Agency for Medical Research and Development (AMED)
  grantid: JP23wm0125008
– fundername: Japan Agency for Medical Research and Development (AMED)
  grantid: JP23jm0110019
– fundername: Japan Agency for Medical Research and Development (AMED)
  grantid: JP23wm0125008
  funderid: https://doi.org/10.13039/100009619
– fundername: Japan Agency for Medical Research and Development (AMED)
  grantid: JP23jm0110019
  funderid: https://doi.org/10.13039/100009619
– fundername: Japan Agency for Medical Research and Development (AMED)
  grantid: JP23fk0108624
  funderid: https://doi.org/10.13039/100009619
– fundername: ;
  grantid: JP23wm0125008
– fundername: ;
  grantid: JP23fk0108624
– fundername: ;
  grantid: JP23jm0110019
GroupedDBID ---
-~X
0R~
18M
29L
2WC
39C
4.4
53G
5GY
5RE
5VS
85S
AAFWJ
AAGFI
ABPPZ
ACGFO
ACNCT
ADBBV
AENEX
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CS3
DIK
E3Z
EBS
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
N9A
O9-
OK1
P2P
RHI
RNS
RPM
RSF
RYH
TR2
UPT
W2D
W8F
WH7
WOQ
YQT
~02
~KM
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
RHF
UCJ
7X8
5PM
ID FETCH-LOGICAL-a471t-41439697c763889f9457b79b10d07593bb6804c893a9bdccc619bd332ea8206e3
ISSN 0022-538X
1098-5514
IngestDate Thu Aug 21 18:35:23 EDT 2025
Fri Jul 11 02:54:52 EDT 2025
Wed Jul 24 04:33:25 EDT 2024
Wed Feb 19 02:00:20 EST 2025
Tue Jul 01 01:32:45 EDT 2025
Thu Jun 26 23:00:48 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Ekpoma virus 2
Ekpoma virus 1
glycoprotein
Mundri virus
Bas-Congo virus
Tibrogargan virus
tibrovirus
Language English
License All Rights Reserved. https://doi.org/10.1128/ASMCopyrightv2
All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-a471t-41439697c763889f9457b79b10d07593bb6804c893a9bdccc619bd332ea8206e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Department of Pathology, University of Texas Medical Branch, Galveston, Texas, USA
The authors declare no conflict of interest.
ORCID 0000-0001-8303-318X
0000-0003-2464-6642
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/11265436
PMID 38953631
PQID 3075375319
PQPubID 23479
PageCount 23
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11265436
proquest_miscellaneous_3075375319
asm2_journals_10_1128_jvi_00499_24
pubmed_primary_38953631
crossref_primary_10_1128_jvi_00499_24
nii_cinii_1871429166522079488
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-07-23
PublicationDateYYYYMMDD 2024-07-23
PublicationDate_xml – month: 07
  year: 2024
  text: 2024-07-23
  day: 23
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of Virology
PublicationTitleAbbrev J Virol
PublicationTitleAlternate J Virol
PublicationYear 2024
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_3_50_2
e_1_3_3_16_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_33_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_40_2
e_1_3_3_5_2
e_1_3_3_7_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_23_2
e_1_3_3_48_2
e_1_3_3_25_2
e_1_3_3_46_2
e_1_3_3_44_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
e_1_3_3_51_2
e_1_3_3_17_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_32_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_28_2
e_1_3_3_49_2
e_1_3_3_24_2
e_1_3_3_47_2
e_1_3_3_26_2
e_1_3_3_45_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
Roche, S, Albertini, AAV, Lepault, J, Bressanelli, S, Gaudin, Y (B14) 2008; 65
Nakayama, E, Tomabechi, D, Matsuno, K, Kishida, N, Yoshida, R, Feldmann, H, Takada, A (B46) 2011; 204 Suppl 3
Maruyama, J, Miyamoto, H, Kajihara, M, Ogawa, H, Maeda, K, Sakoda, Y, Yoshida, R, Takada, A (B32) 2014; 88
Belot, L, Ouldali, M, Roche, S, Legrand, P, Gaudin, Y, Albertini, AA (B13) 2020; 16
Beilstein, F, Abou Hamdan, A, Raux, H, Belot, L, Ouldali, M, Albertini, AA, Gaudin, Y (B22) 2020; 32
Jemielity, S, Wang, JJ, Chan, YK, Ahmed, AA, Li, W, Monahan, S, Bu, X, Farzan, M, Freeman, GJ, Umetsu, DT, Dekruyff, RH, Choe, H (B34) 2013; 9
Yang, F, Lin, S, Ye, F, Yang, J, Qi, J, Chen, Z, Lin, X, Wang, J, Yue, D, Cheng, Y, Chen, Z, Chen, H, You, Y, Zhang, Z, Yang, Y, Yang, M, Sun, H, Li, Y, Cao, Y, Yang, S, Wei, Y, Gao, GF, Lu, G (B12) 2020; 27
Rehman, S, Bishnoi, S, Roy, R, Kumari, A, Jayakumar, H, Gupta, S, Kar, P, Pattnaik, AK, Nayak, D (B24) 2022; 7
Matsuno, K, Kishida, N, Usami, K, Igarashi, M, Yoshida, R, Nakayama, E, Shimojima, M, Feldmann, H, Irimura, T, Kawaoka, Y, Takada, A (B31) 2010; 84
Munis, AM, Bentley, EM, Takeuchi, Y (B17) 2020; 20
Cybinski, DH, St. George, TD, Standfast, HA, McGregor, A (B6) 1980; 5
Marzi, A, Gramberg, T, Simmons, G, Möller, P, Rennekamp, AJ, Krumbiegel, M, Geier, M, Eisemann, J, Turza, N, Saunier, B, Steinkasserer, A, Becker, S, Bates, P, Hofmann, H, Pöhlmann, S (B30) 2004; 78
Moller-Tank, S, Maury, W (B35) 2014; 468–470
Nakayama, E, Yokoyama, A, Miyamoto, H, Igarashi, M, Kishida, N, Matsuno, K, Marzi, A, Feldmann, H, Ito, K, Saijo, M, Takada, A (B43) 2010; 17
Di Lella, S, Herrmann, A, Mair, CM (B26) 2016; 110
Nikolic, J, Belot, L, Raux, H, Legrand, P, Gaudin, Y, A Albertini, A (B16) 2018; 9
Takada, A, Fujioka, K, Tsuiji, M, Morikawa, A, Higashi, N, Ebihara, H, Kobasa, D, Feldmann, H, Irimura, T, Kawaoka, Y (B29) 2004; 78
Amara, A, Mercer, J (B36) 2015; 13
Noda, T, Sagara, H, Suzuki, E, Takada, A, Kida, H, Kawaoka, Y (B45) 2002; 76
Roche, S, Rey, FA, Gaudin, Y, Bressanelli, S (B15) 2007; 315
Saito, T, Hattori, T, Okuya, K, Manzoor, R, Miyamoto, H, Kajihara, M, Takada, A (B41) 2022; 13
Gibbs, EPJ, Calisher, CH, Tesh, RB, Lazuick, JS, Bowen, R, Greiner, EC (B8) 1989; 19
Jumper, J, Evans, R, Pritzel, A, Green, T, Figurnov, M, Ronneberger, O, Tunyasuvunakool, K, Bates, R, Žídek, A, Potapenko, A (B50) 2021; 596
Cybinski, DH, Gard, GP (B7) 1986; 39
B4
Fontana, D, Kratje, R, Etcheverrigaray, M, Prieto, C (B25) 2014; 32
Mirdita, M, Schütze, K, Moriwaki, Y, Heo, L, Ovchinnikov, S, Steinegger, M (B49) 2022; 19
Steffen, I, Liss, NM, Schneider, BS, Fair, JN, Chiu, CY, Simmons, G (B19) 2013; 87
Maruyama, J, Nao, N, Miyamoto, H, Maeda, K, Ogawa, H, Yoshida, R, Igarashi, M, Takada, A (B40) 2016; 488
Edridge, AWD, Abd-Elfarag, G, Deijs, M, Jebbink, MF, Boele van Hensbroek, M, van der Hoek, L (B3) 2022; 14
Yang, G, Ojha, CR, Russell, CJ (B27) 2021; 17
B48
Simmons, G, Reeves, JD, Grogan, CC, Vandenberghe, LH, Baribaud, F, Whitbeck, JC, Burke, E, Buchmeier, MJ, Soilleux, EJ, Riley, JL, Doms, RW, Bates, P, Pöhlmann, S (B33) 2003; 305
Lauck, M, Yú, SQ, Caì, Y, Hensley, LE, Chiu, CY, O’Connor, DH, Kuhn, JH (B9) 2015; 3
Ortega, V, Stone, JA, Contreras, EM, Iorio, RM, Aguilar, HC (B21) 2019; 29
Higashi, N, Fujioka, K, Denda-Nagai, K, Hashimoto, S-I, Nagai, S, Sato, T, Fujita, Y, Morikawa, A, Tsuiji, M, Miyata-Takeuchi, M, Sano, Y, Suzuki, N, Yamamoto, K, Matsushima, K, Irimura, T (B38) 2002; 277
Takada, A, Robison, C, Goto, H, Sanchez, A, Murti, KG, Whitt, MA, Kawaoka, Y (B47) 1997; 94
Shepherd, JG, Davis, C, Streicker, DG, Thomson, EC (B11) 2023; 12
Bach, P, Kamphuis, E, Odermatt, B, Sutter, G, Buchholz, CJ, Kalinke, U (B23) 2007; 178
Grard, G, Fair, JN, Lee, D, Slikas, E, Steffen, I, Muyembe, J-J, Sittler, T, Veeraraghavan, N, Ruby, JG, Wang, C, Makuwa, M, Mulembakani, P, Tesh, RB, Mazet, J, Rimoin, AW, Taylor, T, Schneider, BS, Simmons, G, Delwart, E, Wolfe, ND, Chiu, CY, Leroy, EM (B1) 2012; 8
Walker, PJ, Kongsuwan, K (B18) 1999; 80
Hattori, T, Saito, T, Miyamoto, H, Kajihara, M, Igarashi, M, Takada, A (B42) 2022; 14
Sun, X, Belouzard, S, Whittaker, GR (B20) 2008; 283
Stremlau, MH, Andersen, KG, Folarin, OA, Grove, JN, Odia, I, Ehiane, PE, Omoniwa, O, Omoregie, O, Jiang, P-P, Yozwiak, NL (B2) 2015; 9
Tassaneetrithep, B, Burgess, TH, Granelli-Piperno, A, Trumpfheller, C, Finke, J, Sun, W, Eller, MA, Pattanapanyasat, K, Sarasombath, S, Birx, DL, Steinman, RM, Schlesinger, S, Marovich, MA (B28) 2003; 197
Takada, A, Feldmann, H, Stroeher, U, Bray, M, Watanabe, S, Ito, H, McGregor, M, Kawaoka, Y (B44) 2003; 77
Caì, Y, Yú, S, Jangra, RK, Postnikova, EN, Wada, J, Tesh, RB, Whelan, SPJ, Lauck, M, Wiley, MR, Finch, CL, Radoshitzky, SR, O’Connor, DH, Palacios, G, Chandran, K, Chiu, CY, Kuhn, JH (B37) 2019; 10
Babayan, SA, Orton, RJ, Streicker, DG (B39) 2018; 362
Belot, L, Albertini, A, Gaudin, Y (B10) 2019; 104
Kuhn, JH, Pān, H, Chiu, CY, Stremlau, M (B5) 2020; 12
References_xml – ident: e_1_3_3_30_2
  doi: 10.1128/jvi.78.6.2943-2947.2004
– ident: e_1_3_3_23_2
  doi: 10.1016/j.celrep.2020.108042
– ident: e_1_3_3_27_2
  doi: 10.1016/j.bpj.2016.04.035
– ident: e_1_3_3_34_2
  doi: 10.1006/viro.2002.1730
– ident: e_1_3_3_25_2
  doi: 10.1021/acsomega.2c03517
– ident: e_1_3_3_2_2
  doi: 10.1371/journal.ppat.1002924
– ident: e_1_3_3_3_2
  doi: 10.1371/journal.pntd.0003631
– ident: e_1_3_3_20_2
  doi: 10.1128/JVI.01183-13
– ident: e_1_3_3_31_2
  doi: 10.1128/JVI.78.21.12090-12095.2004
– ident: e_1_3_3_38_2
  doi: 10.3389/fmicb.2019.00856
– ident: e_1_3_3_24_2
  doi: 10.4049/jimmunol.178.9.5839
– ident: e_1_3_3_13_2
  doi: 10.1016/j.chom.2019.12.012
– ident: e_1_3_3_39_2
  doi: 10.1074/jbc.M202104200
– ident: e_1_3_3_51_2
  doi: 10.1038/s41586-021-03819-2
– ident: e_1_3_3_42_2
  doi: 10.1128/mbio.03060-21
– ident: e_1_3_3_7_2
  doi: 10.1016/0378-1135(80)90029-2
– ident: e_1_3_3_14_2
  doi: 10.1371/journal.ppat.1008383
– ident: e_1_3_3_47_2
  doi: 10.1093/infdis/jir334
– ident: e_1_3_3_10_2
  doi: 10.1128/genomeA.00089-15
– ident: e_1_3_3_44_2
  doi: 10.1128/CVI.00170-10
– ident: e_1_3_3_22_2
  doi: 10.1093/glycob/cwy053
– ident: e_1_3_3_50_2
  doi: 10.1038/s41592-022-01488-1
– ident: e_1_3_3_32_2
  doi: 10.1128/JVI.02021-09
– ident: e_1_3_3_35_2
  doi: 10.1371/journal.ppat.1003232
– ident: e_1_3_3_28_2
  doi: 10.1371/journal.ppat.1009910
– ident: e_1_3_3_17_2
  doi: 10.1038/s41467-018-03432-4
– ident: e_1_3_3_8_2
  doi: 10.1071/bi9860225
– ident: e_1_3_3_40_2
  doi: 10.1126/science.aap9072
– ident: e_1_3_3_12_2
  doi: 10.3390/biology12060878
– ident: e_1_3_3_46_2
  doi: 10.1128/jvi.76.10.4855-4865.2002
– ident: e_1_3_3_37_2
  doi: 10.1038/nrmicro3469
– ident: e_1_3_3_43_2
  doi: 10.3390/v14102124
– ident: e_1_3_3_18_2
  doi: 10.1080/14712598.2020.1787981
– ident: e_1_3_3_33_2
  doi: 10.1128/JVI.02265-13
– ident: e_1_3_3_48_2
  doi: 10.1073/pnas.94.26.14764
– ident: e_1_3_3_9_2
  doi: 10.1016/0378-1135(89)90079-5
– ident: e_1_3_3_45_2
  doi: 10.1128/jvi.77.2.1069-1074.2003
– ident: e_1_3_3_5_2
– ident: e_1_3_3_29_2
  doi: 10.1084/jem.20021840
– ident: e_1_3_3_16_2
  doi: 10.1126/science.1135710
– ident: e_1_3_3_49_2
  doi: 10.1101/2021.10.04.463034
– ident: e_1_3_3_21_2
  doi: 10.1074/jbc.M708955200
– ident: e_1_3_3_4_2
  doi: 10.3390/v14020210
– ident: e_1_3_3_15_2
  doi: 10.1007/s00018-008-7534-3
– ident: e_1_3_3_6_2
  doi: 10.3390/v12030252
– ident: e_1_3_3_11_2
  doi: 10.1016/bs.aivir.2019.05.003
– ident: e_1_3_3_26_2
  doi: 10.1016/j.vaccine.2014.02.031
– ident: e_1_3_3_19_2
  doi: 10.1099/0022-1317-80-5-1211
– ident: e_1_3_3_36_2
  doi: 10.1016/j.virol.2014.09.009
– ident: e_1_3_3_41_2
  doi: 10.1016/j.virol.2015.11.002
– volume: 12
  year: 2023
  ident: B11
  article-title: Emerging rhabdoviruses and human infection
  publication-title: Biology (Basel)
  doi: 10.3390/biology12060878
– volume: 315
  start-page: 843
  year: 2007
  end-page: 848
  ident: B15
  article-title: Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G
  publication-title: Science
  doi: 10.1126/science.1135710
– volume: 9
  year: 2018
  ident: B16
  article-title: Structural basis for the recognition of LDL-receptor family members by VSV glycoprotein
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-03432-4
– volume: 104
  start-page: 147
  year: 2019
  end-page: 183
  ident: B10
  article-title: Structural and cellular biology of rhabdovirus entry
  publication-title: Adv Virus Res
  doi: 10.1016/bs.aivir.2019.05.003
– volume: 80
  start-page: 1211
  year: 1999
  end-page: 1220
  ident: B18
  article-title: Deduced structural model for animal rhabdovirus glycoproteins
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-80-5-1211
– volume: 283
  start-page: 6418
  year: 2008
  end-page: 6427
  ident: B20
  article-title: Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M708955200
– volume: 362
  start-page: 577
  year: 2018
  end-page: 580
  ident: B39
  article-title: Predicting reservoir hosts and arthropod vectors from evolutionary signatures in RNA virus genomes
  publication-title: Science
  doi: 10.1126/science.aap9072
– volume: 204 Suppl 3
  start-page: S978
  year: 2011
  end-page: 85
  ident: B46
  article-title: Antibody-dependent enhancement of Marburg virus infection
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jir334
– volume: 488
  start-page: 43
  year: 2016
  end-page: 50
  ident: B40
  article-title: Characterization of the glycoproteins of bat-derived influenza viruses
  publication-title: Virology
  doi: 10.1016/j.virol.2015.11.002
– volume: 13
  year: 2022
  ident: B41
  article-title: Molecular mechanisms underlying the cellular entry and host range restriction of Lujo virus
  publication-title: mBio
  doi: 10.1128/mbio.03060-21
– volume: 88
  start-page: 99
  year: 2014
  end-page: 109
  ident: B32
  article-title: Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus
  publication-title: J Virol
  doi: 10.1128/JVI.02265-13
– volume: 10
  start-page: 856
  year: 2019
  ident: B37
  article-title: Human, nonhuman primate, and bat cells are broadly susceptible to Tibrovirus particle cell entry
  publication-title: Front Microbiol
  doi: 10.3389/fmicb.2019.00856
– volume: 84
  start-page: 5140
  year: 2010
  end-page: 5147
  ident: B31
  article-title: Different potential of C-type lectin-mediated entry between Marburg virus strains
  publication-title: J Virol
  doi: 10.1128/JVI.02021-09
– volume: 77
  start-page: 1069
  year: 2003
  end-page: 1074
  ident: B44
  article-title: Identification of protective epitopes on Ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses
  publication-title: J Virol
  doi: 10.1128/jvi.77.2.1069-1074.2003
– volume: 78
  start-page: 2943
  year: 2004
  end-page: 2947
  ident: B29
  article-title: Human macrophage C-type lectin specific for galactose and N -acetylgalactosamine promotes filovirus entry
  publication-title: J Virol
  doi: 10.1128/jvi.78.6.2943-2947.2004
– volume: 8
  year: 2012
  ident: B1
  article-title: A novel rhabdovirus associated with acute hemorrhagic fever in Central Africa
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002924
– volume: 5
  start-page: 301
  year: 1980
  end-page: 308
  ident: B6
  article-title: Isolation of tibrogargan virus, a new Australian rhabdovirus, from Culicoides brevitarsis
  publication-title: Vet Microbiol
  doi: 10.1016/0378-1135(80)90029-2
– volume: 29
  start-page: 2
  year: 2019
  end-page: 21
  ident: B21
  article-title: Addicted to sugar: roles of glycans in the order Mononegavirales
  publication-title: Glycobiology
  doi: 10.1093/glycob/cwy053
– volume: 277
  start-page: 20686
  year: 2002
  end-page: 20693
  ident: B38
  article-title: The macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cells
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M202104200
– volume: 27
  start-page: 441
  year: 2020
  end-page: 453
  ident: B12
  article-title: Structural analysis of rabies virus glycoprotein reveals pH-dependent conformational changes and interactions with a neutralizing antibody
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2019.12.012
– volume: 76
  start-page: 4855
  year: 2002
  end-page: 4865
  ident: B45
  article-title: Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP
  publication-title: J Virol
  doi: 10.1128/jvi.76.10.4855-4865.2002
– volume: 12
  year: 2020
  ident: B5
  article-title: Human tibroviruses: commensals or lethal pathogens?
  publication-title: Viruses
  doi: 10.3390/v12030252
– volume: 305
  start-page: 115
  year: 2003
  end-page: 123
  ident: B33
  article-title: DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells
  publication-title: Virology
  doi: 10.1006/viro.2002.1730
– volume: 32
  start-page: 2799
  year: 2014
  end-page: 2804
  ident: B25
  article-title: Rabies virus-like particles expressed in HEK293 cells
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2014.02.031
– ident: B4
  article-title: Genus: tibrovirus | ICTV . Available from : https://ictv.global/report/chapter/rhabdoviridae/rhabdoviridae/tibrovirus . Retrieved 8 Dec 2023 .
– volume: 39
  start-page: 225
  year: 1986
  end-page: 232
  ident: B7
  article-title: Isolation of a new rhabdovirus in Australia related to Tibrogargan virus
  publication-title: Aust J Biol Sci
  doi: 10.1071/bi9860225
– volume: 9
  year: 2013
  ident: B34
  article-title: TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003232
– volume: 468–470
  start-page: 565
  year: 2014
  end-page: 580
  ident: B35
  article-title: Phosphatidylserine receptors: enhancers of enveloped virus entry and infection
  publication-title: Virology
  doi: 10.1016/j.virol.2014.09.009
– volume: 94
  start-page: 14764
  year: 1997
  end-page: 14769
  ident: B47
  article-title: A system for functional analysis of Ebola virus glycoprotein
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.94.26.14764
– volume: 87
  start-page: 9558
  year: 2013
  end-page: 9568
  ident: B19
  article-title: Characterization of the bas-Congo virus glycoprotein and its function in pseudotyped viruses
  publication-title: J Virol
  doi: 10.1128/JVI.01183-13
– volume: 32
  start-page: 108042
  year: 2020
  ident: B22
  article-title: Identification of a pH-sensitive switch in VSV-G and a crystal structure of the G pre-fusion state highlight the VSV-G structural transition pathway
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2020.108042
– volume: 9
  year: 2015
  ident: B2
  article-title: Discovery of novel rhabdoviruses in the blood of healthy individuals from West Africa
  publication-title: PLoS Negl Trop Dis
  doi: 10.1371/journal.pntd.0003631
– volume: 110
  start-page: 2293
  year: 2016
  end-page: 2301
  ident: B26
  article-title: Modulation of the pH stability of influenza virus hemagglutinin: a host cell adaptation strategy
  publication-title: Biophys J
  doi: 10.1016/j.bpj.2016.04.035
– volume: 14
  year: 2022
  ident: B42
  article-title: Single nucleotide variants of the human TIM-1 IgV domain with reduced ability to promote viral entry into cells
  publication-title: Viruses
  doi: 10.3390/v14102124
– volume: 16
  year: 2020
  ident: B13
  article-title: Crystal structure of Mokola virus glycoprotein in its post-fusion conformation
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1008383
– volume: 17
  year: 2021
  ident: B27
  article-title: Relationship between hemagglutinin stability and influenza virus persistence after exposure to low pH or supraphysiological heating
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1009910
– volume: 596
  start-page: 583
  year: 2021
  end-page: 589
  ident: B50
  article-title: Highly accurate protein structure prediction with AlphaFold
  publication-title: Nature
  doi: 10.1038/s41586-021-03819-2
– volume: 65
  start-page: 1716
  year: 2008
  end-page: 1728
  ident: B14
  article-title: Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-008-7534-3
– volume: 17
  start-page: 1723
  year: 2010
  end-page: 1728
  ident: B43
  article-title: Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies
  publication-title: Clin Vaccine Immunol
  doi: 10.1128/CVI.00170-10
– volume: 3
  year: 2015
  ident: B9
  article-title: Genome sequence of bivens arm virus, a tibrovirus belonging to the species Tibrogargan virus (Mononegavirales: Rhabdoviridae)
  publication-title: Genome Announc
  doi: 10.1128/genomeA.00089-15
– volume: 19
  start-page: 141
  year: 1989
  end-page: 150
  ident: B8
  article-title: Bivens arm virus: a new rhabdovirus isolated from Culicoides insignis in Florida and related to Tibrogargan virus of Australia
  publication-title: Vet Microbiol
  doi: 10.1016/0378-1135(89)90079-5
– volume: 178
  start-page: 5839
  year: 2007
  end-page: 5847
  ident: B23
  article-title: Vesicular Stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies
  publication-title: J Immunol
  doi: 10.4049/jimmunol.178.9.5839
– volume: 7
  start-page: 32840
  year: 2022
  end-page: 32848
  ident: B24
  article-title: Emerging biomedical applications of the vesicular stomatitis virus glycoprotein
  publication-title: ACS Omega
  doi: 10.1021/acsomega.2c03517
– ident: B48
  article-title: Evans R , O’Neill M , Pritzel A , Antropova N , Senior A , Green T , Žídek A , Bates R , Blackwell S , Yim J , Ronneberger O , Bodenstein S , Zielinski M , Bridgland A , Potapenko A , Cowie A , Tunyasuvunakool K , Jain R , Clancy E , Kohli P , Jumper J , Hassabis D . 2022 . Protein complex prediction with AlphaFold-multimer . bioRxiv . doi: 10.1101/2021.10.04.463034
– volume: 19
  start-page: 679
  year: 2022
  end-page: 682
  ident: B49
  article-title: ColabFold: making protein folding accessible to all
  publication-title: Nat Methods
  doi: 10.1038/s41592-022-01488-1
– volume: 78
  start-page: 12090
  year: 2004
  end-page: 12095
  ident: B30
  article-title: DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus
  publication-title: J Virol
  doi: 10.1128/JVI.78.21.12090-12095.2004
– volume: 13
  start-page: 461
  year: 2015
  end-page: 469
  ident: B36
  article-title: Viral apoptotic mimicry
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro3469
– volume: 14
  year: 2022
  ident: B3
  article-title: Divergent rhabdovirus discovered in a patient with new-onset nodding syndrome
  publication-title: Viruses
  doi: 10.3390/v14020210
– volume: 197
  start-page: 823
  year: 2003
  end-page: 829
  ident: B28
  article-title: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells
  publication-title: J Exp Med
  doi: 10.1084/jem.20021840
– volume: 20
  start-page: 1187
  year: 2020
  end-page: 1201
  ident: B17
  article-title: A tool with many applications: vesicular stomatitis virus in research and medicine
  publication-title: Expert Opin Biol Ther
  doi: 10.1080/14712598.2020.1787981
SSID ssib017579904
ssib001492792
ssj0014464
ssib058493363
Score 2.4604552
Snippet Human tibroviruses are poorly characterized emerging rhabdoviruses associated with either asymptomatic infection or severe disease with a case fatality rate as...
Tibroviruses are novel rhabdoviruses detected in humans, cattle, and arthropods. Four tibroviruses are known to infect humans: Bas-Congo virus (BASV), Ekpoma...
SourceID pubmedcentral
proquest
asm2
pubmed
crossref
nii
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e0049924
SubjectTerms Amino Acid Sequence
Animals
Antibodies, Viral - immunology
Cell Line
Glycosylation
HEK293 Cells
Humans
Mice
Mucin-1 - metabolism
Viral Envelope Proteins - genetics
Viral Envelope Proteins - metabolism
Viral Tropism
Virology
Virus Internalization
Virus-Cell Interactions
Title Characterization of human tibrovirus envelope glycoproteins
URI https://cir.nii.ac.jp/crid/1871429166522079488
https://www.ncbi.nlm.nih.gov/pubmed/38953631
https://journals.asm.org/doi/10.1128/jvi.00499-24
https://www.proquest.com/docview/3075375319
https://pubmed.ncbi.nlm.nih.gov/PMC11265436
Volume 98
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZoEaiXijcpFAUEpypLEidOLE5QgRZQubCVyimyHYeaZZOqSSrt_nrGzrsPCbhYUezY0sxk5hvbM4PQa49IUPrCdVJMUifAzHVozEMHMx5JiVOWmTpkR9_I_Dj4chKeDOWOTHRJxWdic21cyf9wFd4BX3WU7D9wtp8UXsAz8Bda4DC0f8Xjwz7b8mZAfmZXvgIvuLhQ53WpQ9n0tSB58PP3WhQmL4Nqt-iuglId9TbeZz-q87Vc1s4HtlEVWxmk-UOXORJ9hM93pkwppoMFW8ryVA06rdIJSNoeloNT3s-q1gxExHw1hxWXxXjzwQ_0rmYTHzyTjcLU-Ug16hprVBqPJCcaqUdpPKwmaPqq7vZ1PMKvCzUzo5zpMKD82crwESBWiElrO6a5sruuLXTbB7fBuNifv_anSuD6Bl3wgx-_HS-1g-52H4NxZuXKnwCVrVyp63yQy1dpR9hkcQ_ttvyz3zcSch_dkvkDdKcpM7p-iN5dlhO7yGwjJ_YgJ3YnJ_ZETh6h408fF4dzpy2a4TDAGZUTAACmhEYCDEcc04wGYcQjyj03BXRIMeckdgMBMJVRngohwIPmKca-ZDqVv8SP0XZe5PIpsj2PcKJTPMoUB4ylNPKyzM88sApCX2-00CtNqKT9I8rEOJR-nABhE0PYxA8s9KYjY3LWJFC5Ydw-0DgRSrceuPEAlDxCwD1wwWTEsYVedtRPQAPqYy2Wy6IuE7BSIY60LbHQk4Yb_UodTy0UT_jUD9DZ1ac9uTo1WdZ1bF0YYLJ346TP0M7wTzxH29V5LfcBolb8hZG7PyCUkBo
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+human+tibrovirus+envelope+glycoproteins&rft.jtitle=Journal+of+virology&rft.au=Munyeku-Bazitama%2C+Yannick&rft.au=Saito%2C+Takeshi&rft.au=Hattori%2C+Takanari&rft.au=Miyamoto%2C+Hiroko&rft.date=2024-07-23&rft.eissn=1098-5514&rft.volume=98&rft.issue=7&rft.spage=e0049924&rft_id=info:doi/10.1128%2Fjvi.00499-24&rft_id=info%3Apmid%2F38953631&rft.externalDocID=38953631
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon